did not reflect activities of daily living or function in daily life. If patients without confounding health factors can perform the test, it can be a useful marker to follow disease progression. 6MWD is important in the monitoring of patients pre-lung transplantation, those with pulmonary hypertension, and those unable to perform PFTs. For people with SARD-ILD, we conditionally recommend against monitoring with bronchoscopy. There was no published evidence. The panel was not in favor of